-
1دورية أكاديمية
المؤلفون: Alberto Calvo-Garcia, Esther Ramírez Herráiz, Irene María Llorente Cubas, Blanca Varas De Dios, Juana Benedí González, Alberto Morell Baladrón, Rosario García-Vicuña
المصدر: Journal of Clinical Medicine, Vol 13, Iss 9, p 2517 (2024)
مصطلحات موضوعية: JAK-inhibitor, baricitinib, rheumatoid arthritis, real-word data, persistence, adherence, Medicine
وصف الملف: electronic resource
-
2
المؤلفون: Isidoro González-Álvaro, Irene Llorente Cubas, Esther Ramírez Herráiz, Iciar Cañamares Orbis, Rosario García-Vicuña, Juana Benedí González, Leticia Merino Meléndez, Alberto Morell Baladrón
المصدر: Medicina clinica. 155(1)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Proportional hazards model, Retrospective cohort study, medicine.disease, Persistence (computer science), Discontinuation, Arthritis, Rheumatoid, 03 medical and health sciences, Regimen, 0302 clinical medicine, Treatment Outcome, Rheumatoid arthritis, Internal medicine, Antirheumatic Agents, Cohort, Medicine, Humans, Rituximab, 030212 general & internal medicine, business, medicine.drug, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4704744fe9dfe6428b12f81c9ade5e9Test
https://pubmed.ncbi.nlm.nih.gov/31848023Test -
3
المصدر: Medicina clinica. 152(9)
مصطلحات موضوعية: Inflammatory bowel disease, Proinflammatory cytokine, Autoimmune Diseases, Pathogenesis, 03 medical and health sciences, 0302 clinical medicine, Piperidines, Psoriasis, medicine, Humans, Immunologic Factors, Janus Kinase Inhibitors, Pyrroles, 030212 general & internal medicine, Sulfonamides, Tofacitinib, business.industry, JAK-STAT signaling pathway, medicine.disease, Inflammatory Bowel Diseases, STAT Transcription Factors, Pyrimidines, Purines, Rheumatoid arthritis, Immunology, Azetidines, Pyrazoles, business, Janus kinase
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c7a80f75a92ecf43995e09711fc99cTest
https://pubmed.ncbi.nlm.nih.gov/30527218Test -
4
المؤلفون: Raimon Sanmartí, Jesús Sanz-Sanz, Rosario García-Vicuña, Benito Dorantes-Calderón, Carmen Martinez-Fernandez, Paloma Vela, Isidoro González-Álvaro, José Andrés Román Ivorra, José Luis Poveda-Andrés, Olatz Ibarra-Barrueta, Santiago Muñoz-Fernández, Emilio Martín-Mola, Blanca Hernández-Cruz, Alberto Morell-Baladrón, Alicia Herrero-Ambrosio, Emilio Monte-Boquet, Francisco Javier de Toro-Santos
المساهمون: [Gonzalez-Alvaro, Isidoro, Garcia-Vicuna, Rosario] Hosp Univ La Princesa, Inst Invest Sanitaria La Princesa, Rheumatol Serv, Madrid 28006, Spain, [Herrero-Ambrosio, Alicia] IdiPaz, Hosp Univ La Paz, Hosp Pharm Serv, Madrid, Spain, [Martin-Mola, Emilio] Univ Autonoma Madrid, IdiPaz, Hosp Univ La Paz, Rheumatol Serv, Madrid, Spain, [Morell-Baladron, Alberto] Hosp Univ La Princesa, Hosp Pharm Serv, Madrid 28006, Spain, [Sanz-Sanz, Jesus] Hosp Puerta de Hierro, Rheumatol Serv, Madrid, Spain, [Munoz-Fernandez, Santiago] Univ Europea Madrid, Hosp Univ Infanta Sofia, Rheumatol Serv, Madrid, Spain
المصدر: Rheumatology (Oxford, England)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
RUC. Repositorio da Universidade da Coruña
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madridمصطلحات موضوعية: Optimization, rheumatoid arthritis, medicine.medical_specialty, bDMARD, Delphi method, Dose reduction, Pharmacy, Biologics, Arthritis, Rheumatoid, Psoriatic arthritis, Tratamiento médico, Rheumatology, Risk–benefit ratio, Internal medicine, ankylosing spondylitis, medicine, Humans, Pharmacology (medical), Spondylitis, Ankylosing, biologics, Hospital pharmacy, Rheumatoid arthritis, risk/benefit ratio, Intensive care medicine, psoriatic arthritis, Ankylosing spondylitis, Biological Products, Medicamento, Dose-Response Relationship, Drug, business.industry, Arthritis, Psoriatic, Sociedad Española de Farmacia Hospitalaria, Clinical Science, medicine.disease, Ankylosing spondolytis, Systematic review, dose reduction, Sociedad Española de Reumatología, Physical therapy, cDMARD, business, Enfermedad, optimization, Reumatismo, Risk/benefit ratio
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1921c7ea66bc4d43aa73edcdb91f2465Test
https://pubmed.ncbi.nlm.nih.gov/25526976Test -
5
المؤلفون: Vicente Escudero-Vilaplana, Nicolás Trovato-López, Alberto Morell-Baladrón, Estefanía Alañón-Plaza, Esther Ramírez-Herráiz, María José Bellini, Ana Herranz-Alonso, María Sanjurjo-Sáez, José María Bellón-Cano
المصدر: SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Journal of Pharmacy & Pharmaceutical Sciences, Vol 15, Iss 3 (2012)
Scopus-Elsevierمصطلحات موضوعية: Male, lcsh:RS1-441, Pharmaceutical Science, Receptors, Tumor Necrosis Factor, Etanercept, Arthritis, Rheumatoid, immune system diseases, Medicine, skin and connective tissue diseases, Antibodies, Monoclonal, purl.org/becyt/ford/3.1 [https], Middle Aged, Farmacia, Medicina Básica, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Female, purl.org/becyt/ford/3 [https], Immunotherapy, medicine.drug, Adult, musculoskeletal diseases, medicine.medical_specialty, Farmacología y Farmacia, CIENCIAS MÉDICAS Y DE LA SALUD, Medicina, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, lcsh:Pharmacy and materia medica, Internal medicine, Adalimumab, Humans, Medical prescription, Aged, Retrospective Studies, Pharmacology, business.industry, Tumor Necrosis Factor-alpha, lcsh:RM1-950, Retrospective cohort study, medicine.disease, Infliximab, Surgery, Anti-tnf, lcsh:Therapeutics. Pharmacology, Immunoglobulin G, Observational study, business, Rheumatism
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134441cb329162507976c851567b7336Test
http://sedici.unlp.edu.ar/handle/10915/96808Test